DORA ESCOBEDO: Open Payments
NPI 1376567412 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 13 payments from 7 companies in 2025. Trend: 2023 $195 · 2024 $369 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $229 |
| Daiichi Sankyo Inc. | 3 | $184 |
| AstraZeneca Pharmaceuticals LP | 3 | $176 |
| Gilead Sciences, Inc. | 2 | $156 |
| SANOFI-AVENTIS U.S. LLC | 1 | $150 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: BLINCYTO, REZUROCK, Trodelvy, LIBTAYO, Enhertu, DATROWAY, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
